<?xml version="1.0" encoding="utf-8"?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="2003-10-24" modified="2020-10-07" version="151">
<accession>Q96FA3</accession>
<accession>Q96SM0</accession>
<accession>Q9GZY5</accession>
<accession>Q9HCX0</accession>
<name>PELI1_HUMAN</name>
<protein>
<recommendedName>
<fullName>E3 ubiquitin-protein ligase pellino homolog 1</fullName>
<shortName>Pellino-1</shortName>
<ecNumber evidence="8">2.3.2.27</ecNumber>
</recommendedName>
<alternativeName>
<fullName>Pellino-related intracellular-signaling molecule</fullName>
</alternativeName>
<alternativeName>
<fullName evidence="9">RING-type E3 ubiquitin transferase pellino homolog 1</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary">PELI1</name>
<name type="synonym">PRISM</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="2000" name="Immunogenetics" volume="52" first="145" last="149">
<title>Pellino-related sequences from Caenorhabditis elegans and Homo sapiens.</title>
<authorList>
<person name="Rich T."/>
<person name="Allen R.L."/>
<person name="Lucas A.-M."/>
<person name="Trowsdale J."/>
</authorList>
<dbReference type="PubMed" id="11132151"/>
<dbReference type="DOI" id="10.1007/s002510000249"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<source>
<tissue>Thymus</tissue>
</source>
</reference>
<reference key="2">
<citation type="journal article" date="2001" name="Cytogenet. Cell Genet." volume="92" first="172" last="174">
<title>Assignment of homologous genes, Peli1/PELI1 and Peli2/PELI2, for the Pelle adaptor protein Pellino to mouse chromosomes 11 and 14 and human chromosomes 2p13.3 and 14q21, respectively, by physical and radiation hybrid mapping.</title>
<authorList>
<person name="Resch K."/>
<person name="Jockusch H."/>
<person name="Schmitt-John T."/>
</authorList>
<dbReference type="PubMed" id="11306823"/>
<dbReference type="DOI" id="10.1159/000056895"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
</reference>
<reference key="3">
<citation type="submission" date="2000-08" db="EMBL/GenBank/DDBJ databases">
<title>PRISM, a novel mediator of Toll/IL-1 signalling.</title>
<authorList>
<person name="Kennedy E.J."/>
<person name="Moynagh P.N."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
</reference>
<reference key="4">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
<source>
<tissue>Ovary</tissue>
<tissue>Placenta</tissue>
<tissue>Testis</tissue>
</source>
</reference>
<reference key="5">
<citation type="journal article" date="2004" name="Nat. Genet." volume="36" first="40" last="45">
<title>Complete sequencing and characterization of 21,243 full-length human cDNAs.</title>
<authorList>
<person name="Ota T."/>
<person name="Suzuki Y."/>
<person name="Nishikawa T."/>
<person name="Otsuki T."/>
<person name="Sugiyama T."/>
<person name="Irie R."/>
<person name="Wakamatsu A."/>
<person name="Hayashi K."/>
<person name="Sato H."/>
<person name="Nagai K."/>
<person name="Kimura K."/>
<person name="Makita H."/>
<person name="Sekine M."/>
<person name="Obayashi M."/>
<person name="Nishi T."/>
<person name="Shibahara T."/>
<person name="Tanaka T."/>
<person name="Ishii S."/>
<person name="Yamamoto J."/>
<person name="Saito K."/>
<person name="Kawai Y."/>
<person name="Isono Y."/>
<person name="Nakamura Y."/>
<person name="Nagahari K."/>
<person name="Murakami K."/>
<person name="Yasuda T."/>
<person name="Iwayanagi T."/>
<person name="Wagatsuma M."/>
<person name="Shiratori A."/>
<person name="Sudo H."/>
<person name="Hosoiri T."/>
<person name="Kaku Y."/>
<person name="Kodaira H."/>
<person name="Kondo H."/>
<person name="Sugawara M."/>
<person name="Takahashi M."/>
<person name="Kanda K."/>
<person name="Yokoi T."/>
<person name="Furuya T."/>
<person name="Kikkawa E."/>
<person name="Omura Y."/>
<person name="Abe K."/>
<person name="Kamihara K."/>
<person name="Katsuta N."/>
<person name="Sato K."/>
<person name="Tanikawa M."/>
<person name="Yamazaki M."/>
<person name="Ninomiya K."/>
<person name="Ishibashi T."/>
<person name="Yamashita H."/>
<person name="Murakawa K."/>
<person name="Fujimori K."/>
<person name="Tanai H."/>
<person name="Kimata M."/>
<person name="Watanabe M."/>
<person name="Hiraoka S."/>
<person name="Chiba Y."/>
<person name="Ishida S."/>
<person name="Ono Y."/>
<person name="Takiguchi S."/>
<person name="Watanabe S."/>
<person name="Yosida M."/>
<person name="Hotuta T."/>
<person name="Kusano J."/>
<person name="Kanehori K."/>
<person name="Takahashi-Fujii A."/>
<person name="Hara H."/>
<person name="Tanase T.-O."/>
<person name="Nomura Y."/>
<person name="Togiya S."/>
<person name="Komai F."/>
<person name="Hara R."/>
<person name="Takeuchi K."/>
<person name="Arita M."/>
<person name="Imose N."/>
<person name="Musashino K."/>
<person name="Yuuki H."/>
<person name="Oshima A."/>
<person name="Sasaki N."/>
<person name="Aotsuka S."/>
<person name="Yoshikawa Y."/>
<person name="Matsunawa H."/>
<person name="Ichihara T."/>
<person name="Shiohata N."/>
<person name="Sano S."/>
<person name="Moriya S."/>
<person name="Momiyama H."/>
<person name="Satoh N."/>
<person name="Takami S."/>
<person name="Terashima Y."/>
<person name="Suzuki O."/>
<person name="Nakagawa S."/>
<person name="Senoh A."/>
<person name="Mizoguchi H."/>
<person name="Goto Y."/>
<person name="Shimizu F."/>
<person name="Wakebe H."/>
<person name="Hishigaki H."/>
<person name="Watanabe T."/>
<person name="Sugiyama A."/>
<person name="Takemoto M."/>
<person name="Kawakami B."/>
<person name="Yamazaki M."/>
<person name="Watanabe K."/>
<person name="Kumagai A."/>
<person name="Itakura S."/>
<person name="Fukuzumi Y."/>
<person name="Fujimori Y."/>
<person name="Komiyama M."/>
<person name="Tashiro H."/>
<person name="Tanigami A."/>
<person name="Fujiwara T."/>
<person name="Ono T."/>
<person name="Yamada K."/>
<person name="Fujii Y."/>
<person name="Ozaki K."/>
<person name="Hirao M."/>
<person name="Ohmori Y."/>
<person name="Kawabata A."/>
<person name="Hikiji T."/>
<person name="Kobatake N."/>
<person name="Inagaki H."/>
<person name="Ikema Y."/>
<person name="Okamoto S."/>
<person name="Okitani R."/>
<person name="Kawakami T."/>
<person name="Noguchi S."/>
<person name="Itoh T."/>
<person name="Shigeta K."/>
<person name="Senba T."/>
<person name="Matsumura K."/>
<person name="Nakajima Y."/>
<person name="Mizuno T."/>
<person name="Morinaga M."/>
<person name="Sasaki M."/>
<person name="Togashi T."/>
<person name="Oyama M."/>
<person name="Hata H."/>
<person name="Watanabe M."/>
<person name="Komatsu T."/>
<person name="Mizushima-Sugano J."/>
<person name="Satoh T."/>
<person name="Shirai Y."/>
<person name="Takahashi Y."/>
<person name="Nakagawa K."/>
<person name="Okumura K."/>
<person name="Nagase T."/>
<person name="Nomura N."/>
<person name="Kikuchi H."/>
<person name="Masuho Y."/>
<person name="Yamashita R."/>
<person name="Nakai K."/>
<person name="Yada T."/>
<person name="Nakamura Y."/>
<person name="Ohara O."/>
<person name="Isogai T."/>
<person name="Sugano S."/>
</authorList>
<dbReference type="PubMed" id="14702039"/>
<dbReference type="DOI" id="10.1038/ng1285"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 78-418</scope>
<source>
<tissue>Teratocarcinoma</tissue>
</source>
</reference>
<reference key="6">
<citation type="journal article" date="2003" name="J. Biol. Chem." volume="278" first="10952" last="10956">
<title>Pellino 1 is required for interleukin-1 (IL-1)-mediated signaling through its interaction with the IL-1 receptor-associated kinase 4 (IRAK4)-IRAK-tumor necrosis factor receptor-associated factor 6 (TRAF6) complex.</title>
<authorList>
<person name="Jiang Z."/>
<person name="Johnson H.J."/>
<person name="Nie H."/>
<person name="Qin J."/>
<person name="Bird T.A."/>
<person name="Li X."/>
</authorList>
<dbReference type="PubMed" id="12496252"/>
<dbReference type="DOI" id="10.1074/jbc.m212112200"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH IRAK1; IRAK4 AND TRAF6</scope>
</reference>
<reference key="7">
<citation type="journal article" date="2003" name="FEBS Lett." volume="545" first="199" last="202">
<title>Pellino2 activates the mitogen activated protein kinase pathway.</title>
<authorList>
<person name="Jensen L.E."/>
<person name="Whitehead A.S."/>
</authorList>
<dbReference type="PubMed" id="12804775"/>
<dbReference type="DOI" id="10.1016/s0014-5793(03)00533-7"/>
</citation>
<scope>INTERACTION WITH TRAF6 AND MAP3K7</scope>
</reference>
<reference key="8">
<citation type="journal article" date="2006" name="Nat. Immunol." volume="7" first="1057" last="1065">
<title>Smad6 negatively regulates interleukin 1-receptor-Toll-like receptor signaling through direct interaction with the adapter Pellino-1.</title>
<authorList>
<person name="Choi K.C."/>
<person name="Lee Y.S."/>
<person name="Lim S."/>
<person name="Choi H.K."/>
<person name="Lee C.H."/>
<person name="Lee E.K."/>
<person name="Hong S."/>
<person name="Kim I.H."/>
<person name="Kim S.J."/>
<person name="Park S.H."/>
</authorList>
<dbReference type="PubMed" id="16951688"/>
<dbReference type="DOI" id="10.1038/ni1383"/>
</citation>
<scope>INTERACTION WITH IRAK1; IRAK4; MYD88; SMAD6 AND TRAF6</scope>
</reference>
<reference key="9">
<citation type="journal article" date="2007" name="J. Biol. Chem." volume="282" first="29729" last="29737">
<title>Kinase-active interleukin-1 receptor-associated kinases promote polyubiquitination and degradation of the Pellino family: direct evidence for PELLINO proteins being ubiquitin-protein isopeptide ligases.</title>
<authorList>
<person name="Butler M.P."/>
<person name="Hanly J.A."/>
<person name="Moynagh P.N."/>
</authorList>
<dbReference type="PubMed" id="17675297"/>
<dbReference type="DOI" id="10.1074/jbc.m704558200"/>
</citation>
<scope>FUNCTION AS E3 UBIQUITIN LIGASE</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2008" name="Biochem. J." volume="409" first="43" last="52">
<title>The IRAK-catalysed activation of the E3 ligase function of Pellino isoforms induces the Lys63-linked polyubiquitination of IRAK1.</title>
<authorList>
<person name="Ordureau A."/>
<person name="Smith H."/>
<person name="Windheim M."/>
<person name="Peggie M."/>
<person name="Carrick E."/>
<person name="Morrice N."/>
<person name="Cohen P."/>
</authorList>
<dbReference type="PubMed" id="17997719"/>
<dbReference type="DOI" id="10.1042/bj20071365"/>
</citation>
<scope>PHOSPHORYLATION BY IRAK1 AND IRAK4</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2011" name="Mol. Cells" volume="31" first="85" last="89">
<title>Pellino-1, an adaptor protein of interleukin-1 receptor/toll-like receptor signaling, is sumoylated by Ubc9.</title>
<authorList>
<person name="Kim J.H."/>
<person name="Sung K.S."/>
<person name="Jung S.M."/>
<person name="Lee Y.S."/>
<person name="Kwon J.Y."/>
<person name="Choi C.Y."/>
<person name="Park S.H."/>
</authorList>
<dbReference type="PubMed" id="21120624"/>
<dbReference type="DOI" id="10.1007/s10059-011-0006-x"/>
</citation>
<scope>SUMOYLATION</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2018" name="Mol. Cell" volume="70" first="920" last="935">
<title>PELI1 selectively targets kinase-active RIP3 for ubiquitylation-dependent proteasomal degradation.</title>
<authorList>
<person name="Choi S.W."/>
<person name="Park H.H."/>
<person name="Kim S."/>
<person name="Chung J.M."/>
<person name="Noh H.J."/>
<person name="Kim S.K."/>
<person name="Song H.K."/>
<person name="Lee C.W."/>
<person name="Morgan M.J."/>
<person name="Kang H.C."/>
<person name="Kim Y.S."/>
</authorList>
<dbReference type="PubMed" id="29883609"/>
<dbReference type="DOI" id="10.1016/j.molcel.2018.05.016"/>
</citation>
<scope>FUNCTION</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>INTERACTION WITH RIPK1; IRAK1 AND RIPK3</scope>
<scope>MUTAGENESIS OF ARG-104; HIS-313 AND CYS-336</scope>
<scope>REGION RING-LIKE DOMAIN</scope>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<comment type="function">
<text evidence="2 5 8">E3 ubiquitin ligase catalyzing the covalent attachment of ubiquitin moieties onto substrate proteins. Involved in the TLR and IL-1 signaling pathways via interaction with the complex containing IRAK kinases and TRAF6. Mediates 'Lys-63'-linked polyubiquitination of IRAK1 allowing subsequent NF-kappa-B activation (PubMed:12496252, PubMed:17675297). Mediates 'Lys-48'-linked polyubiquitination of RIPK3 leading to its subsequent proteasome-dependent degradation; preferentially recognizes and mediates the degradation of the 'Thr-182' phosphorylated form of RIPK3 (PubMed:29883609). Negatively regulates necroptosis by reducing RIPK3 expression (PubMed:29883609). Mediates 'Lys-63'-linked ubiquitination of RIPK1 (PubMed:29883609).</text>
</comment>
<comment type="catalytic activity">
<reaction evidence="8">
<text>S-ubiquitinyl-[E2 ubiquitin-conjugating enzyme]-L-cysteine + [acceptor protein]-L-lysine = [E2 ubiquitin-conjugating enzyme]-L-cysteine + N(6)-ubiquitinyl-[acceptor protein]-L-lysine.</text>
<dbReference type="EC" id="2.3.2.27"/>
</reaction>
</comment>
<comment type="pathway">
<text>Protein modification; protein ubiquitination.</text>
</comment>
<comment type="subunit">
<text evidence="2 3 4 8">Interacts with MAP3K7. Upon IL1B treatment, forms a complex with TRAF6, IRAK1, IRAK4 and MYD88; this complex recruits MAP3K7/TAK1, TAB1 and TAB2 to mediate NF-kappa-B activation. Direct binding of SMAD6 to PELI1 prevents the complex formation and hence negatively regulates IL1R-TLR signaling and eventually NF-kappa-B-mediated gene expression (PubMed:12496252, PubMed:12804775, PubMed:16951688). Interacts (via atypical FHA domain) with RIPK3; preferentially binds to the 'Thr-182' phosphorylated form of RIPK3 (PubMed:29883609). Interacts with RIPK1 and IRAK1 (PubMed:29883609).</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-448369">
<id>Q96FA3</id>
</interactant>
<interactant intactId="EBI-11977093">
<id>Q6ZS10</id>
<label>CLEC17A</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-448369">
<id>Q96FA3</id>
</interactant>
<interactant intactId="EBI-947360">
<id>Q8N137</id>
<label>CNTROB</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-448369">
<id>Q96FA3</id>
</interactant>
<interactant intactId="EBI-4401517">
<id>O14653</id>
<label>GOSR2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-448369">
<id>Q96FA3</id>
</interactant>
<interactant intactId="EBI-10236940">
<id>Q15735</id>
<label>INPP5J</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-448369">
<id>Q96FA3</id>
</interactant>
<interactant intactId="EBI-358664">
<id>P51617</id>
<label>IRAK1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-448369">
<id>Q96FA3</id>
</interactant>
<interactant intactId="EBI-448378">
<id>Q9NWZ3</id>
<label>IRAK4</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-448369">
<id>Q96FA3</id>
</interactant>
<interactant intactId="EBI-11911016">
<id>P80188</id>
<label>LCN2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-448369">
<id>Q96FA3</id>
</interactant>
<interactant intactId="EBI-351935">
<id>P02545</id>
<label>LMNA</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-448369">
<id>Q96FA3</id>
</interactant>
<interactant intactId="EBI-1390763">
<id>Q13442</id>
<label>PDAP1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-448369">
<id>Q96FA3</id>
</interactant>
<interactant intactId="EBI-6660974">
<id>Q9H426</id>
<label>RIMS4</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-448369">
<id>Q96FA3</id>
</interactant>
<interactant intactId="EBI-2337775">
<id>Q9H3D4</id>
<label>TP63</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-448369">
<id>Q96FA3</id>
</interactant>
<interactant intactId="EBI-358993">
<id>Q15645</id>
<label>TRIP13</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-448369">
<id>Q96FA3</id>
</interactant>
<interactant intactId="EBI-2107455">
<id>Q08AM6</id>
<label>VAC14</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-448369">
<id>Q96FA3</id>
</interactant>
<interactant intactId="EBI-712969">
<id>Q9Y3C0</id>
<label>WASHC3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="tissue specificity">
<text evidence="8">Expressed at high levels in normal skin but decreased in keratinocytes from toxic epidermal necrolysis (TEN) patients (at protein level).</text>
</comment>
<comment type="PTM">
<text evidence="6">Phosphorylation by IRAK1 and IRAK4 enhances its E3 ligase activity.</text>
</comment>
<comment type="PTM">
<text evidence="7">Sumoylated.</text>
</comment>
<comment type="similarity">
<text evidence="9">Belongs to the pellino family.</text>
</comment>
<comment type="sequence caution" evidence="9">
<conflict type="erroneous initiation">
<sequence resource="EMBL-CDS" id="AAH11419" version="1"/>
</conflict>
<text>Truncated N-terminus.</text>
</comment>
<comment type="sequence caution" evidence="9">
<conflict type="erroneous initiation">
<sequence resource="EMBL-CDS" id="BAB55280" version="1"/>
</conflict>
<text>Truncated N-terminus.</text>
</comment>
<dbReference type="EC" id="2.3.2.27" evidence="8"/>
<dbReference type="EMBL" id="AJ278859">
<property type="protein sequence ID" value="CAC04320.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF302505">
<property type="protein sequence ID" value="AAG15393.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF300987">
<property type="protein sequence ID" value="AAG17451.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC011419">
<property type="protein sequence ID" value="AAH11419.1"/>
<property type="status" value="ALT_INIT"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC050019">
<property type="protein sequence ID" value="AAH50019.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC063611">
<property type="protein sequence ID" value="AAH63611.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK027668">
<property type="protein sequence ID" value="BAB55280.1"/>
<property type="status" value="ALT_INIT"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS1876.1"/>
<dbReference type="RefSeq" id="NP_065702.2">
<property type="nucleotide sequence ID" value="NM_020651.3"/>
</dbReference>
<dbReference type="RefSeq" id="XP_011531296.1">
<property type="nucleotide sequence ID" value="XM_011532994.2"/>
</dbReference>
<dbReference type="RefSeq" id="XP_016860009.1">
<property type="nucleotide sequence ID" value="XM_017004520.1"/>
</dbReference>
<dbReference type="SMR" id="Q96FA3"/>
<dbReference type="BioGRID" id="121418">
<property type="interactions" value="53"/>
</dbReference>
<dbReference type="CORUM" id="Q96FA3"/>
<dbReference type="DIP" id="DIP-32488N"/>
<dbReference type="IntAct" id="Q96FA3">
<property type="interactions" value="26"/>
</dbReference>
<dbReference type="MINT" id="Q96FA3"/>
<dbReference type="STRING" id="9606.ENSP00000351789"/>
<dbReference type="iPTMnet" id="Q96FA3"/>
<dbReference type="PhosphoSitePlus" id="Q96FA3"/>
<dbReference type="BioMuta" id="PELI1"/>
<dbReference type="DMDM" id="37999756"/>
<dbReference type="EPD" id="Q96FA3"/>
<dbReference type="MassIVE" id="Q96FA3"/>
<dbReference type="MaxQB" id="Q96FA3"/>
<dbReference type="PaxDb" id="Q96FA3"/>
<dbReference type="PeptideAtlas" id="Q96FA3"/>
<dbReference type="PRIDE" id="Q96FA3"/>
<dbReference type="ProteomicsDB" id="76505"/>
<dbReference type="Antibodypedia" id="16046">
<property type="antibodies" value="222 antibodies"/>
</dbReference>
<dbReference type="DNASU" id="57162"/>
<dbReference type="Ensembl" id="ENST00000358912">
<property type="protein sequence ID" value="ENSP00000351789"/>
<property type="gene ID" value="ENSG00000197329"/>
</dbReference>
<dbReference type="GeneID" id="57162"/>
<dbReference type="KEGG" id="hsa:57162"/>
<dbReference type="UCSC" id="uc002sct.5">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="57162"/>
<dbReference type="DisGeNET" id="57162"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000197329.11"/>
<dbReference type="GeneCards" id="PELI1"/>
<dbReference type="HGNC" id="HGNC:8827">
<property type="gene designation" value="PELI1"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000197329">
<property type="expression patterns" value="Tissue enhanced (bone)"/>
</dbReference>
<dbReference type="MIM" id="614797">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="neXtProt" id="NX_Q96FA3"/>
<dbReference type="OpenTargets" id="ENSG00000197329"/>
<dbReference type="PharmGKB" id="PA33172"/>
<dbReference type="eggNOG" id="KOG3842">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00950000183050"/>
<dbReference type="HOGENOM" id="CLU_029221_2_0_1"/>
<dbReference type="InParanoid" id="Q96FA3"/>
<dbReference type="KO" id="K11964"/>
<dbReference type="OMA" id="TFAFNPC"/>
<dbReference type="OrthoDB" id="837213at2759"/>
<dbReference type="PhylomeDB" id="Q96FA3"/>
<dbReference type="TreeFam" id="TF314338"/>
<dbReference type="PathwayCommons" id="Q96FA3"/>
<dbReference type="Reactome" id="R-HSA-9020702">
<property type="pathway name" value="Interleukin-1 signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-937039">
<property type="pathway name" value="IRAK1 recruits IKK complex"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-975144">
<property type="pathway name" value="IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation"/>
</dbReference>
<dbReference type="SignaLink" id="Q96FA3"/>
<dbReference type="SIGNOR" id="Q96FA3"/>
<dbReference type="UniPathway" id="UPA00143"/>
<dbReference type="BioGRID-ORCS" id="57162">
<property type="hits" value="5 hits in 876 CRISPR screens"/>
</dbReference>
<dbReference type="ChiTaRS" id="PELI1">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="GeneWiki" id="PELI1"/>
<dbReference type="GenomeRNAi" id="57162"/>
<dbReference type="Pharos" id="Q96FA3">
<property type="development level" value="Tbio"/>
</dbReference>
<dbReference type="PRO" id="PR:Q96FA3"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 2"/>
</dbReference>
<dbReference type="RNAct" id="Q96FA3">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000197329">
<property type="expression patterns" value="Expressed in bone marrow and 238 other tissues"/>
</dbReference>
<dbReference type="ExpressionAtlas" id="Q96FA3">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="Q96FA3">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0000778">
<property type="term" value="C:condensed nuclear chromosome kinetochore"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0061630">
<property type="term" value="F:ubiquitin protein ligase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0034450">
<property type="term" value="F:ubiquitin-ubiquitin ligase activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0070498">
<property type="term" value="P:interleukin-1-mediated signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0060546">
<property type="term" value="P:negative regulation of necroptotic process"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032088">
<property type="term" value="P:negative regulation of NF-kappaB transcription factor activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0042130">
<property type="term" value="P:negative regulation of T cell proliferation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0030890">
<property type="term" value="P:positive regulation of B cell proliferation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0001819">
<property type="term" value="P:positive regulation of cytokine production"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0043123">
<property type="term" value="P:positive regulation of I-kappaB kinase/NF-kappaB signaling"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0031398">
<property type="term" value="P:positive regulation of protein ubiquitination"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0034141">
<property type="term" value="P:positive regulation of toll-like receptor 3 signaling pathway"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0034145">
<property type="term" value="P:positive regulation of toll-like receptor 4 signaling pathway"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0043161">
<property type="term" value="P:proteasome-mediated ubiquitin-dependent protein catabolic process"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0070936">
<property type="term" value="P:protein K48-linked ubiquitination"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0070534">
<property type="term" value="P:protein K63-linked ubiquitination"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000209">
<property type="term" value="P:protein polyubiquitination"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0008592">
<property type="term" value="P:regulation of Toll signaling pathway"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0043331">
<property type="term" value="P:response to dsRNA"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0032496">
<property type="term" value="P:response to lipopolysaccharide"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0008063">
<property type="term" value="P:Toll signaling pathway"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="InterPro" id="IPR006800">
<property type="entry name" value="Pellino_fam"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR12098">
<property type="entry name" value="PTHR12098"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF04710">
<property type="entry name" value="Pellino"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PIRSF" id="PIRSF038886">
<property type="entry name" value="Pellino"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0808">Transferase</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<keyword id="KW-0833">Ubl conjugation pathway</keyword>
<feature type="chain" description="E3 ubiquitin-protein ligase pellino homolog 1" id="PRO_0000194172">
<location>
<begin position="1"/>
<end position="418"/>
</location>
</feature>
<feature type="domain" description="FHA; atypical" evidence="1">
<location>
<begin position="13"/>
<end position="200"/>
</location>
</feature>
<feature type="region of interest" description="Ring-like domain; necessary for ubiqitination of RIPK3" evidence="8">
<location>
<begin position="311"/>
<end position="399"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of ability to ubiquitinate RIPK3. Loss of interaction with RIPK1, IRAK1 and RIPK3." evidence="8">
<original>R</original>
<variation>A</variation>
<location>
<position position="104"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of ability to ubiquitinate RIPK3. No loss of interaction with RIPK3." evidence="8">
<original>H</original>
<variation>A</variation>
<location>
<position position="313"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of ability to ubiquitinate RIPK3. No loss of interaction with RIPK3." evidence="8">
<original>C</original>
<variation>A</variation>
<location>
<position position="336"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; CAC04320." ref="1" evidence="9">
<original>S</original>
<variation>F</variation>
<location>
<position position="11"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 5; BAB55280." ref="5" evidence="9">
<original>F</original>
<variation>S</variation>
<location>
<position position="100"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 5; BAB55280." ref="5" evidence="9">
<original>S</original>
<variation>P</variation>
<location>
<position position="260"/>
</location>
</feature>
<evidence key="1" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q9HAT8"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12496252"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12804775"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16951688"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17675297"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17997719"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21120624"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="29883609"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000305"/>
<sequence length="418" mass="46286" checksum="233318A45E7546F7" modified="2003-10-24" version="2">MFSPDQENHPSKAPVKYGELIVLGYNGSLPNGDRGRRKSRFALFKRPKANGVKPSTVHIACTPQAAKAISNKDQHSISYTLSRAQTVVVEYTHDSNTDMFQIGRSTESPIDFVVTDTVPGSQSNSDTQSVQSTISRFACRIICERNPPFTARIYAAGFDSSKNIFLGEKAAKWKTSDGQMDGLTTNGVLVMHPRNGFTEDSKPGIWREISVCGNVFSLRETRSAQQRGKMVEIETNQLQDGSLIDLCGATLLWRTAEGLSHTPTVKHLEALRQEINAARPQCPVGFNTLAFPSMKRKDVVDEKQPWVYLNCGHVHGYHNWGNKEERDGKDRECPMCRSVGPYVPLWLGCEAGFYVDAGPPTHAFSPCGHVCSEKTTAYWSQIPLPHGTHTFHAACPFCAHQLAGEQGYIRLIFQGPLD</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>

